Summary
Cognizant Technology Solutions Corporation (CTSH) reported its second-quarter 2016 financial results on August 5, 2016. The company demonstrated consistent revenue growth, with a 9.2% increase year-over-year to $3.37 billion for the quarter. This growth was driven by strong performance in its Manufacturing/Retail/Logistics and Other segments, as well as continued demand for digital technologies and consulting services across its key geographic markets, particularly North America. However, net income saw a significant decline of 39.9% to $252.4 million, largely due to a one-time incremental income tax expense of $190 million related to an India Cash Remittance transaction. Despite this, the company's non-GAAP diluted earnings per share showed an increase of 10.1% to $0.87, indicating underlying operational strength. Cognizant also highlighted its ongoing investment in talent and service offerings, strategic client expansion, and plans for opportunistic acquisitions. The company maintained a strong liquidity position with substantial cash and short-term investments.
Financial Highlights
48 data points| Revenue | $3.37B |
| SG&A Expenses | $654.00M |
| Operating Income | $591.00M |
| Interest Expense | $5.00M |
| Net Income | $252.00M |
| EPS (Basic) | $0.42 |
| EPS (Diluted) | $0.41 |
| Shares Outstanding (Basic) | 606.00M |
| Shares Outstanding (Diluted) | 609.00M |
Key Highlights
- 1Revenue grew by 9.2% to $3.37 billion in Q2 2016 compared to the prior year's quarter.
- 2Net income decreased by 39.9% to $252.4 million, primarily impacted by a $190 million incremental income tax expense from an India Cash Remittance.
- 3Non-GAAP diluted earnings per share increased by 10.1% to $0.87, demonstrating operational resilience.
- 4Manufacturing/Retail/Logistics and Other segments showed robust revenue growth at 14.2% and 11.2% respectively.
- 5The company repurchased $50 million of its Class A common stock during the quarter, with an expanded repurchase program authorized through December 31, 2018.
- 6A $27.4 million pre-tax loss was recognized on an amended fixed-price healthcare contract.
- 7Cash, cash equivalents, and short-term investments stood at $4.48 billion as of June 30, 2016, indicating strong liquidity.